Oncor Divesting All Non-Oncology Ventures In Effort To Refocus Company
This article was originally published in The Gray Sheet
Executive Summary
Gaithersburg, Maryland-based Oncor, Inc. has entered agreements with clinical laboratories to diagnose up to 30% of the roughly 180,000 new breast cancer cases in the U.S. annually with the Inform HER-2/neu breast cancer test, President and Chief Operating Officer Cecil Kost reported at a March 26 teleconference.